01 January 1996
Bone formation markers and parathormone levels in children with end-stage renal disease during the early period of growth hormone treatment
Maria Sieniawska, Małgorzata Pańczyk-Tomaszewska, Paweł GrzesiowskiMed Sci Monit 1996; 2(1): CR77-81 :: ID: 499526
Abstract
The aim of the study was to estimate the changes in bone formation markers (procollagen lC - PICP0, osteocalcin - OC, alkaline phosphatase - AP) and parathormone (PTH intact) in children with end-stage renal disease during the first 6 months of recombinant human growth hormone (rhGH) treatment. 13 children, aged 6-13 years were included in the study, 7 on haemodialysis (HD) and 6 on continuous ambulatory peritoneal dialysis (CAPD). The patients received rhGH (1-1.1 IU/kg/week s.c.), alfacalcidol (0.038-0.13 mg/kg body weight/week) and calcium carbonate (50-150 mg/kg body weight/day). Morphometric analysis of iliac crest bone performed in 12 children prior to rhGH treatment revealed osteitis fibrosa in 1 case (8.3%), mild lesion of secondary hyperparathyroidism in 8 cases (66.8%), adynamic bone disease in 1 case (8.3%) and normal histology in 2 (16.6%). The height increment after 6 months was 3.2-5.9 cm in 11 children and 0.8 cm in 1 child. In the first 3 months of treatment the PICP concentrations increased in 11 children, but the OC levels increased in 5 children only. After 6 months the OC levels increased in 11 children. The AP activity increased in 9 out of 13 patients. In 7 children the levels of intact PTH were 7 to 24 times higher that the baseline levels, exceeding 200 mg/ml. The increased PTH levels were probably the result of inadequate dosage of vitamin D active metabolite in children with improved growth velocity.
Keywords: end-stage renal disease, recombinant human growth hormone, parathormone, osteocalcin, procollagen lC
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
07 May 2024 : Clinical Research
Treatment of AVN-Induced Proximal Pole Scaphoid Nonunion Using a Fifth and Fourth Extensor Compartmental Ar...Med Sci Monit In Press; DOI: 10.12659/MSM.944553
16 Mar 2024 : Clinical Research
Diagnostic Efficiency of ACR-TIRADS Score for Differentiating Benign and Malignant Thyroid Nodules of Vario...Med Sci Monit In Press; DOI: 10.12659/MSM.943228
08 May 2024 : Clinical Research
Effect of Individualized PEEP Guided by Driving Pressure on Diaphragm Function in Patients Undergoing Lapar...Med Sci Monit In Press; DOI: 10.12659/MSM.944022
21 Mar 2024 : Clinical Research
Impact of Serum Vitamin D, B6, and B12 and Cognitive Functions on Quality of Life in Peri- and Postmenopaus...Med Sci Monit In Press; DOI: 10.12659/MSM.943249
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952